These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6535821)

  • 1. Problems of urban leprosy control with special reference to case holding.
    Koticha KK; Patre BB; Nair PR
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):482-7. PubMed ID: 6535821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study.
    Mahajan VK; Sharma NL; Rana P; Sood N
    Indian J Lepr; 2003; 75(1):17-24. PubMed ID: 15253391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to leprosy work in south Bombay--a preliminary communication.
    Daniel JR; Maniar JK; Ganapati R
    Indian J Lepr; 1984; 56(2):280-91. PubMed ID: 6548498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of drug compliance in leprosy patients attending urban centres--a longitudinal study.
    Naik SS; Gole DH; Neet MR; Dongre VV
    Indian J Lepr; 1990; 62(3):305-9. PubMed ID: 2262714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of multidrug therapy blister-calendar packs in an urban leprosy control programme in Bombay.
    Revankar CR; Dhamale CB; Ganapati R
    Lepr Rev; 1991 Sep; 62(3):336. PubMed ID: 1795592
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in new case-detection leprosy in Bihar, India.
    Vijayakumaran P; Prasad B; Krishnamurthy P
    Indian J Lepr; 2006; 78(2):145-51. PubMed ID: 16927849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can adherence with multi-drug therapy in leprosy be improved?
    Williams MC
    Lepr Rev; 2005 Jun; 76(2):160-1. PubMed ID: 16038249
    [No Abstract]   [Full Text] [Related]  

  • 9. "Instant" new leprosy case-detection: an experience in Bihar State in India.
    Rao TP; Krishnamurthy P; Vijayakumaran P; Mishra RK; Samy MS
    Indian J Lepr; 2003; 75(1):9-15. PubMed ID: 15253390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.
    Honrado ER; Tallo V; Balis AC; Chan GP; Cho SN
    Dermatol Clin; 2008 Apr; 26(2):221-9, vi. PubMed ID: 18346553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of relapse after MDT in a district in West Bengal, India.
    Haldar A; Mahapatra BS; Mundle M; Haldar S; Saha AK
    Indian J Lepr; 2003; 75(1):1-8. PubMed ID: 15253389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of attitudes, beliefs and behaviour of leprosy patients, family members and PHC workers towards multidrug therapy in Yangzhou and Dongtai Districts of China.
    Chen XS; Ye GY; Jiang C; Li WZ; Bian J; Wang H; Chen W
    Lepr Rev; 1997 Jun; 68(2):155-61. PubMed ID: 9217355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
    Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy among industrial workers in Bombay, India. Studies in retrospect and prospect.
    Koticha KK; Pade SS; Nair PR; Patre BB
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):488-95. PubMed ID: 6535822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status.
    Sehgal VN; Sardana K; Dogra S
    J Dermatolog Treat; 2008; 19(2):82-91. PubMed ID: 17852638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field follow-up of leprosy cases in an urban area.
    Revankar CR; Angane S; Ganapati R
    Indian J Lepr; 1984; 56(4):861-7. PubMed ID: 6549457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
    Ganapati R; Revankar CR; Naik SS
    Lepr India; 1983 Jul; 55(3):485-9. PubMed ID: 6656206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone compliance in an urban field project.
    Revankar CR; Naik SS; Ganapati R
    Lepr India; 1983 Jan; 55(1):117-21. PubMed ID: 6876753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.